Authors: Ayaz S, Ullah H, Khan FR, Waleed M, Ullah Jan R, Ali I, Ullah A. DOI: 10.7759/cureus.99180 Abstract Summary...
Read moreDetailsAuthors: Bermejo-Martínez D, Castro-Sánchez E, Marqués-Sánchez P. DOI: 10.1002/nop2.70370 Abstract Summary The 2022 mpox outbreak primarily affected men who have...
Read moreDetailsAuthors: Andrea C. Tricco, Jamie Brehaut, Maggie H. Chen, David MoherDOI: 10.1371/journal.pone.0003684Abstract SummaryOnly 80% of Cochrane review protocols were published...
Authors: Jacobsen L, Fernandes DM, Nagel ML, Souza EL, Viana DPDC. DOI: 10.3390/jcm15010048 Abstract Summary Estradiol pellets provide sustained hormone...
Authors: Hsia B, Moroz M, Sipes E, Chang A, Jundi R, Rafie S, Silberstein P, Tauseef A. DOI: 10.3389/fruro.2025.1647133 Abstract...
Authors: Gnimadi TAC, Kadio KJO, Camara A, Hounmenou CG, Camara SC, Bangoura ST, Ogoumma EH, Keita AK, Kaba D, Camara...
Authors: Poyatos L, Núñez-Montero M, Hladun O, Rosa G, Martín S, Videla S, Martínez-Couselo S, Ventura M, La Maida N,...
Authors: Dey G, Fritz-Laylin L, Oliferenko S, Tromer EC. DOI: 10.1242/jcs.264348 Abstract Summary Evolutionary cell biology is experiencing a renaissance,...
Authors: Suenghataiphorn T, Tribuddharat N, Danpanichkul P, Kulthamrongsri N. DOI: 10.2478/abm-2025-0030 Abstract Summary Southeast Asian nations face a shifting disease...
Authors: Shintaku DN, Lopes MA, Beraldo RF, Oliveira ECS, Herrerias GSP, Oliveira ACB, Baima JP, Barbosa WF, Silva GF, Sassaki...
Authors: Bank-Mikkelsen EM, Grimm D, Wehland M. DOI: 10.3390/ijms262311431 Abstract Summary Aprocitentan, a novel dual endothelin receptor antagonist, shows promise...
Read moreDetailsAuthors: Bermejo-Martínez D, Castro-Sánchez E, Marqués-Sánchez P. DOI: 10.1002/nop2.70370 Abstract Summary The 2022 mpox outbreak primarily affected men who have sex with men, prompting targeted interventions. However, this focus risks stigmatization similar to the...
Read moreDetailsAuthors: Bank-Mikkelsen EM, Grimm D, Wehland M. DOI: 10.3390/ijms262311431 Abstract Summary Aprocitentan, a novel dual endothelin receptor antagonist, shows promise for treating resistant hypertension. Studies reveal significant blood pressure reductions within 14 days at...
Read moreDetailsAuthors: Ayaz S, Ullah H, Khan FR, Waleed M, Ullah Jan R, Ali I, Ullah A. DOI: 10.7759/cureus.99180 Abstract Summary Slow flow/no-reflow during primary PCI for STEMI affects 25% of patients and significantly worsens...
Read moreDetailsAuthors: Leanza C, Giusti MA, Miceli V, Zito G, Tinnirello R, Iannolo G, Galante A, Emanuele F, Amato M, Lo Iacono G, Lo Re V, Gruttadauria S, Calogero AE, Pinzani M, Mattina A. DOI:...
Read moreDetailsAuthors: Shilo-Benjamini Y, Milgram J, Lavy E, Quint M, Barasch D, Cern A, Barenholz Y. DOI: 10.3389/fvets.2025.1746266 Abstract Summary A single injection of liposomal cannabidiol provided pain relief for up to 4 weeks in...
Read moreDetailsWe develop advanced AI systems to enhance data-driven knowledge discovery and scientific research worldwide.
© 2026 Klastrovanie Co., Ltd. All rights reserved.
유한 클라스트로바니에 | 대표자: 정용우 | 사업자등록번호: 373-81-03700
주소: 경기도 안양시 동안구 시민대로 327번길 11-41, 905호 우) 14055
통신판매업신고: 2026-안양동안-0297 (안양시 동안구청)
email: contact@klastrovanie.com
※ 본 서비스는 학술 참고용이며 의료 진단 목적으로 사용할 수 없습니다.